Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Telix Pharmaceuticals

Request full access

Telix Pharmaceuticals is a clinical-stage biopharamaceutical company

Melbourne, AustraliaFounded 2015Biotech & Life Sciences
Valuation $3.42B Market cap · Aug/2026
Revenue $908M Latest reported FY
EBITDA $58M Latest reported FY

At a glance

Status
Listed
Founded
2015
Headquarters
Melbourne, Australia
Listing
IPO 2017
Sector
Biotech & Life Sciences
Outcome tier
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Knowledge graph

Founder mafias, market maps, lists and research connected to this company by Dealroom
Market maps in Biotech & Life Sciences
Market map Companies building biology-native data infrastructure Apr 30, 2026 Market map Rare Disease Therapeutics & Technologies Landscape Market map 1k+ Global Genetics & Genomics startups
Unicorn lists
Biotech & Life Sciences unicorns Unicorn list Biotech & Life Sciences unicorns Unicorns in Australia Unicorn list Unicorns in Australia

News

News Telix teams up with IBA-Framatome JV Ekalia on US astatine-211 production Oct 19, 2026 News Telix begins US commercial launch of Pixclara, the first FDA-approved imaging drug for glioma Oct 6, 2026 News Telix bets $1.7B on ITM to build radiopharma powerhouse Sep 20, 2026

Open roles

Track hiring at Telix PharmaceuticalsOpen roles, team growth and hiring by functionBook a demo
Looking for a job? The startup jobs board lists open roles.Startups hiring now →

Telix Pharmaceuticals in the Melbourne ecosystem

Live from Dealroom

The Telix Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
20 countries with
team presence
🇺🇸 United States54.2%
🇦🇺 Australia16.7%
🇧🇪 Belgium13%
🇬🇧 United Kingdom3.8%
🇨🇭 Switzerland3.6%
Top 5 of 20 shown
Web traffic by country
37K monthly visits
across markets
🇺🇸 United States27.8%
🇦🇺 Australia21.4%
🇯🇵 Japan6.5%
🇨🇦 Canada4.1%
🇬🇧 United Kingdom3.8%
Top 5 markets shown

Patents

Estimated portfolio value
$10M

16 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Telix Pharmaceuticals was the backer or acquirer, 2018–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

12 deals across Telix Pharmaceuticals's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Telix Pharmaceuticals's portfolio, mapped.

        Stage
        Period
        12 of 12 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Telix Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Telix Pharmaceuticals on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles